Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer

Investigative Radiology

Volumn 45, Issue 4, 2010, Pages 217-224

  Ryoo, Inseon ^a   Lee, Jeong Min ^a   Chung, Yong Eun ^a   Park, Hee Sun ^b   Kim, Se Hyung ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Bile duct cancer; Gadobutrol; MR cholangiography

Indexed keywords

GADOBUTROL;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER STAGING; CHOLANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEPATIC ARTERY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE RECONSTRUCTION; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PORTAL VEIN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING;

EID: 77949811247     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181d2eeb1     Document Type: Article

References (45)

1. Lim JH, Park CK. Pathology of cholangiocarcinoma. Abdom Imaging. 2004; 29:540-547.
2. Khan AZ, Makuuchi M. Trends in the surgical management of Klatskin tumours. Br J Surg. 2007;94:393-394.
3. Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet. 2005;366:1303-1314.
4. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663-671.
5. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463-473.
6. Anderson CD, Pinson CW, Berlin J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9:43-57.
7. Hemming AW, Reed AI, Fujita S, et al. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693-699.
8. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234: 507-517.
9. Klempnauer J, Ridder GJ, von Wasielewski R, et al. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol. 1997;15:947-954.
10. Miyazaki M, Ito H, Nakagawa K, et al. Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery. 1998;123:131-136.
11. Gakhal MS, Gheyi VK, Brock RE, et al. Multimodality imaging of biliary malignancies. Surg Oncol Clin N Am. 2009;18:225-239.
12. Endo I, Shimada H, Sugita M, et al. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery. 2007;142:666-675.
13. Nesbit GM, Johnson CD, James EM, et al. Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. Am J Roentgenol. 1988;151:933-938.
14. Unno M, Okumoto T, Katayose Y, et al. Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepato-biliary Pancreat Surg. 2007;14:434-440.
15. Kim HJ, Kim AY, Hong SS, et al. Biliary ductal evaluation of hilar cholangiocarcinoma: three-dimensional direct multi-detector row CT cholan-giographic findings versus surgical and pathologic results\feasibility study. Radiology. 2006;238:300-308.
16. Heslin MJ, Brooks AD, Hochwald SN, et al. A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. Arch Surg. 1998;133:149-154.
17. Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999;134:261-266.
18. Choi JY, Kim MJ, Lee JM, et al. Hilar cholangiocarcinoma: role of preop-erative imaging with sonography, MDCT, MRI, and direct cholangiography. Am J Roentgenol. 2008;191:1448-1457.
19. Hanninen EL, Pech M, Jonas S, et al. Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol. 2005;46:462-470.
20. Manfredi R, Masselli G, Maresca G, et al. MR imaging and MRCP of hilar cholangiocarcinoma. Abdom Imaging. 2003;28:319-325.
21. Zech CJ, Schoenberg SO, Reiser M, et al. Cross-sectional imaging of biliary tumors: current clinical status and future developments. Eur Radiol. 2004; 14:1174-1187.
22. Choi JY, Lee JM, Lee JY, et al. Navigator-triggered isotropic three-dimensional magnetic resonance cholangiopancreatography in the diagnosis of malignant biliary obstructions: comparison with direct cholangiography. J Magn Reson Imaging. 2008;27:94-101.
23. Heilmaier C, Sutter R, Lutz AM, et al. Mapping of hepatic vascular anatomy: dynamic contrast-enhanced parallel MR imaging compared with 64 detector row CT. Radiology. 2007;245:872-880.
24. Hahn G, Sorge I, Gruhn B, et al. Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients. Invest Radiol. 2009;44:776-783.
25. Hammerstingl R, Adam G, Ayuso JR, et al. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial. Invest Radiol. 2009;44:168-176.
26. Idee JM, Port M, Dencausse A, et al. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update. Radiol Clin North Am. 2009;47:855-869.
27. Janus N, Launay-Vacher V, Karie S, et al. Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study. Eur J Radiol. 2010;73:357-359.
28. Seeger A, Kramer U, Fenchel M, et al. Comparison between a linear versus a macrocyclic contrast agent for whole body MR angiography in a clinical routine setting. J Cardiovasc Magn Reson. 2008;10:63.
29. Kim MJ, Mitchell DG, Ito K, et al. Biliary dilatation: differentiation of benign from malignant causes\value of adding conventional MR imaging to MR cholangiopancreatography. Radiology. 2000;214:173-181.
30. Lu DS, Reber HA, Krasny RM, et al. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. Am J Roentgenol. 1997;168:1439-1443.
31. Cho ES, Park MS, Yu JS, et al. Biliary ductal involvement of hilar cholan-giocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr. 2007;31:72-78.
32. Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006;239:113-121.
33. Lee SS, Kim MH, Lee SK, et al. MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma. Gas-trointest Endosc. 2002;56:25-32.
34. Park HS, Lee JM, Choi JY, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. Am J Roentgenol. 2008;190:396-405.
35. Kim HJ, Lee JM, Kim SH, et al. Evaluation of the longitudinal tumor extent of bile duct cancer: value of adding gadolinium-enhanced dynamic imaging to unenhanced images and magnetic resonance cholangiography. J Comput Assist Tomogr. 2007;31:469-474.
36. Choi JY, Kim MJ, Lee JM, et al. Magnetic resonance cholangiography: comparison of two-and three-dimensional sequences for assessment of malignant biliary obstruction. Eur Radiol. 2008;18:78-86.
37. Tillich M, Mischinger HJ, Preisegger KH, et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. Am J Roentgenol. 1998; 171:651-658.
38. Zhong L, Li L, Yao QY. Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques. World J Gastroenterol. 2005;11:3756-3761.
39. Lee MG, Park KB, Shin YM, et al. Preoperative evaluation of hilar cholan-giocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography. World J Surg. 2003;27:278-283.
40. McFarland EG, Kaufman JA, Saini S, et al. Preoperative staging of cancer of the pancreas: value of MR angiography versus conventional angiography in detecting portal venous invasion. Am J Roentgenol. 1996;166:37-43.
41. Attenberger UI, Runge VM, Jackson CB, et al. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T. Invest Radiol. 2009;44:251-256.
42. Saito K, Saito M, Komatu S, et al. Real-time four-dimensional imaging of the heart with multi-detector row CT. Radiographics. 2003;23:e8.
43. Hann LE, Schwartz LH, Panicek DM, et al. Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology. 1998;206:651-656.
44. Akduman EI, Momtahen AJ, Balci NC, et al. Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging. Acad Radiol. 2008;15:641-646.
45. Kim JK, Kim KA, Park BW, et al. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging. 2008;28:714-719.